Searle’s Denosumab biosimilar gains regulatory approval

MG News | September 10, 2025 at 01:08 PM GMT+05:00

0:00

September 10, 2025 (MLN): Searle Company Limited has reached a major milestone as Denosumab, Pakistan’s first biosimilar of its kind, receives regulatory approval.

This development marked a transformative moment in the country’s pharmaceutical sector as it introduced a locally developed biotechnological therapy that expands access and affordability for patients nationwide.

Denosumab, a monoclonal antibody used to treat osteoporosis and cancer-related bone conditions, now enters the market in biosimilar form, offering a cost-effective alternative to imported treatments.

Patients previously burdened by high prices may now benefit from the broader availability of this advanced therapy.

“This approval reflects a commitment to innovation and patient-focused healthcare,” the company stated. “It signals progress toward greater accessibility and long-term value creation.”

It will potentially reshape the biotech landscape and encourage investment in local research and manufacturing.

Copyright Mettis Link News

Related News

Name	Price/Vol	%Chg/NChg
KSE100	167,085.58 225.68M	0.48% 802.03
ALLSHR	101,220.72 685.91M	0.47% 477.65
KSE30	50,772.02 134.57M	0.57% 290.16
KMI30	239,923.35 145.03M	0.77% 1831.31
KMIALLSHR	66,042.80 345.76M	0.65% 425.34
BKTi	45,106.39 29.18M	0.06% 24.91
OGTi	33,583.05 26.44M	1.52% 502.39

Symbol	Bid/Ask	High/Low

Name	Last	High/Low	Chg/%Chg
BITCOIN FUTURES	89,425.00	92,995.00 88,405.00	-3415.00 -3.68%
BRENT CRUDE	63.86	64.09 63.06	0.60 0.95%
RICHARDS BAY COAL MONTHLY	91.00	0.00 0.00	0.10 0.11%
ROTTERDAM COAL MONTHLY	97.25	97.25 97.25	0.05 0.05%
USD RBD PALM OLEIN	1,016.00	1,016.00 1,016.00	0.00 0.00%
CRUDE OIL - WTI	60.14	60.50 59.42	0.47 0.79%
SUGAR #11 WORLD	14.82	15.02 14.73	-0.06 -0.40%